from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2067c/-

LFCtreatmentdescriptionclass of inhibitor

-0.063

Amikacinug/mL Amikacintranslation

0.237

Cap5-10ug/mL Capreomycintranslation

0.791

Rox10-50 ug/mL Roxithromycintranslation

1.421

SM2-5 ug/mL Streptomycintranslation

0.291

Tet5-10 ug/mL Tetracyclinetranslation

-0.281

Rif0.2-5ug/mL Rifampicintranscription

0.674

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.384

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.750

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.845

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.995

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.038

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.477

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.353

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.558

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.505

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.577

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.903

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.717

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.379

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.562

KCN5-20 ug/mL Potassium cyaniderespiration

-0.450

NaN30.2-2 mM Sodium aziderespiration

0.815

Nigericin50 uM Nigericinrespiration

-0.507

TRC10-150 ug/mL Triclosanrespiration

-1.920

TRZ10-25 ug/mL Thioridazinerespiration

1.516

Valinomycin0.5-10 uM Valinomycinrespiration

0.408

ZnSO42 mM ZnSO4respiration

-0.426

menadione6-10 ug/mL Menadionerespiration

0.138

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.329

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.217

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.185

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.268

NRP_1Non-replicating persistence stage 1dosRassociated

0.570

Amp0.2mg/mL AmpicillincellWall

0.112

Cephalexin20-100 ug/mL CephalexincellWall

0.579

Cerulenin0.32-5 ug/mL CerulenincellWall

0.045

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.207

EMB10-20 ug/mL EthambutolcellWall

0.754

Eta12-40 ug/mL EthionamidecellWall

0.506

INH0.2-0.4 ug/mL IsoniazidcellWall

0.894

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.418

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.048

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.078

BZA0.12 mg/mL BenzamidearomaticAmides

-0.243

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.217

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.311

H2O24 mM hydrogen peroxideDNAdamaging

-0.022

Levo10 ug/mL LevofloxacinDNAdamaging

0.889

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.714

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.400

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.642

UVUV-irradiationDNAdamaging

-1.927

ARP41-4 ug/mL Antitubercular compound ARP4?

0.413

Antimycin12.5-50 ug/mL Antimycin A?

-0.199

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.097

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.020

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.195

PA8240.2-2 ug/mL PA-824?

-0.524

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.056

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.044

Verapamil50 uM Verapamil?

-0.146

mercaptoethanol2 mM 2-Mercaptoethanol?

0.440

methoxatin10-20 ug/mL Methoxatin?